EGFR and non-small cell lung carcinoma: Epidermal growth factor receptor (EGFR) protein is a well-studied oncological drug target as it is overexpressed in almost all types of cancers, including non-small cell lung cancer (NSCLC), breast, colon, prostate, etc. [1,2].